Schedule 13G ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Security class unavailable · CUSIP: 75629V104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
24,820,850
Percent of class
13.6600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001088875-23-000056
Form type
SC 13G/A
Filer
BAILLIE GIFFORD & CO
CIK
CIK 1088875
Filed
Jan 24, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub